Frank Rimerman Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,033
Closed -$240K – 640
2026
Q2
$240K Sell
2,033
-68
-3% -$7.85K 0.01% 565
2026
Q1
$251K Sell
2,101
-2,468
-54% -$324K 0.02% 533
2025
Q4
$622K Buy
4,569
+2,486
+119% +$358K 0.04% 326
2025
Q3
$307K Sell
2,083
-47
-2% -$6.52K 0.02% 482
2025
Q2
$276K Sell
2,130
-528
-20% -$63.9K 0.02% 473
2025
Q1
$318K Buy
2,658
+551
+26% +$68.3K 0.03% 396
2024
Q4
$244K Sell
2,107
-49
-2% -$6.2K 0.02% 461
2024
Q3
$291K Buy
2,156
+118
+6% +$15.8K 0.02% 429
2024
Q2
$276K Buy
2,038
+2,029
+22,544% +$276K 0.02% 460
2024
Q1
$1.16K Hold
9
– – ﹤0.01% 307
2023
Q4
$1.03K Buy
+9
New +$898 ﹤0.01% 293

Other funds holding XYL

Frank Rimerman Advisors's XYL Position: Q3 2026 in Review

Frank Rimerman Advisors sold out of Xylem (XYL) in Q3 2026, closing a stake of 2,033 shares — an estimated $240K sold.

Frank Rimerman Advisors first reported a position in XYL in Q4 2023 and held it in 11 quarters. The position peaked at $622K in Q4 2025. 1,076 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Frank Rimerman Advisors reported no remaining Xylem position as of Q3 2026 after selling out during the quarter.
  • Frank Rimerman Advisors sold 2,033 Xylem shares in Q3 2026, an estimated $240K.
  • Frank Rimerman Advisors first reported a position in Xylem in Q4 2023 and held it in 11 quarters.
  • Frank Rimerman Advisors's Xylem position peaked at $622K in Q4 2025.
  • 1,076 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Frank Rimerman Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.